Mechanisms affecting neutrophil migration capacity in breast cancer patients before and after chemotherapy-Reference-Cited by-同舟云学术

Mechanisms affecting neutrophil migration capacity in breast cancer patients before and after chemotherapy

Published:2013-11-21 Issue:2 Volume:73 Page:317-324
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Mendonça Maria Angélica Oliveira,Souto Fabrício O.,Micheli Douglas C.,Alves-Filho José Carlos,Cunha Fernando Q.,Murta Eddie Fernando C.,Tavares-Murta Beatriz M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-013-2348-x.pdf

Reference32 articles.

1. Soehnlein O, Lindbom L (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10:427–439. doi: 10.1038/nri2779

2. Lehrnbecher T, Koehl U, Wittekindt B, Bochennek K, Tramsen L, Klingebiel T, Chanock SJ (2008) Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies. Lancet Oncol 9:269–278. doi: 10.1016/S1470-2045(08)70071-8

3. Ribeiro RA, Flores CA, Cunha FQ, Ferreira SH (1991) IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology 73:472–477

4. Tavares-Murta BM, Cunha FQ, Ferreira SH (1998) The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production. Br J Pharmacol 124:1369–1374. doi: 10.1038/sj.bjp.0701965

5. Niggli V (2003) Signaling to migration in neutrophils: importance of localized pathways. Int J Biochem Cell Biol 35:1619–1638. doi: 10.1016/S1357-2725(03)00144-4

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoplasmic CCR7 (CCR7c) immunoexpression is associated with local tumor recurrence in triple-negative breast cancer;Pathology - Research and Practice;2020-12

2. A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment;Frontiers in Immunology;2020-08-07

3. Prognostic Value of CXCR2 in Breast Cancer;Cancers;2020-07-27

4. Deficits in the IgG + memory B‐cell recovery after anthracycline treatment is confined to the spleen of rhesus macaques;Clinical & Translational Immunology;2020-01

5. Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy;Breast Cancer Research and Treatment;2017-12-12